GSK Consumer Healthcare, Paula Abdul partner to promote Voltaren Arthritis Pain
As it promotes the OTC availability of its recent Rx-to-OTX switch Voltaren Arthritis Pain, GSK Consumer Healthcare is bringing in a big name. The company is teaming up with Paula Abdul, who uses the product for her arthritis pain, to help highlight the product.
“I’m excited to partner with Voltaren Arthritis Pain Gel to share my personal journey with arthritis and success using Voltaren,” Abdul said. “I’ve put my joints through a lot over the years. Dancing, jumping, flipping – it’s my heart and soul, but I’ve been pushing my joints to the limit for decades as a result. When I was diagnosed with arthritis, my doctor prescribed Voltaren which made a huge difference in relieving my pain and helping me move with ease. I am so excited it’s now available OTC at stores nationwide.”
Research conducted by Voltaren in partnership with Wakefield Research found that 82% of respondents surveyed about joint pain said their physical activity has decreased as a result of more time home, and 92% said their joint pain is more severe now than before pandemic-related shelter-in-place orders began taking effect.
“Stay-at-home orders led to a unique set of challenges for those with arthritis,” said Jissan Cherian, director of U.S. OTC Marketing at GSK Consumer Healthcare. “Now, more than ever, we need to offer solutions that help ease the challenge of joint pain and inspire arthritis patients to rediscover the joy of movement, even as we adapt to changing routines and a new way of life.”
Among other findings was the fact that 78% of joint pain sufferers are finding new ways to incorporate activity into their day, but that 31% of those surveyed said they are unhappy about straying from their typical pain-management routine. Fifty-four percent of those surveyed reported more knee pain from walking around on surfaces that offer less support and 51% said they are feeling joint pain due to new quarantine activities — from bread kneading to knitting and gardening, among other activities.
Voltaren currently is the only prescription-strength NSAID topical gel for arthritis available over-the-counter in the United States, GSK Consumer Healthcare said. It is meant to be applied directly to the site of pain to deliver relief from pain.
“As the world leader in pain relief, we have seen how Voltaren has helped people with osteoarthritis treat their pain and improve their quality of life,” Cherian said. “The OTC availability of Voltaren Arthritis Pain helps to provide greater access to an effective topical treatment option for joint pain patients, so more people with osteoarthritis pain can find relief.”